Injectable NAD+: The Longevity Coenzyme That Declines With Age — and How to Restore It
NAD+ is not a supplement trend. It is a fundamental coenzyme present in every living cell, essential to the reactions that generate ATP (cellular energy), regulate gene expression, repair DNA, and activate sirtuin longevity proteins. Its decline with aging is well-documented and biologically significant.
What NAD+ Does
NAD+ functions as an electron carrier in cellular respiration — specifically in the Krebs cycle and oxidative phosphorylation — where it accepts electrons and transfers them to the mitochondrial electron transport chain for ATP production. Without adequate NAD+, mitochondrial efficiency drops, ATP production declines, and cellular energy output falls.
Beyond energy metabolism, NAD+ is the substrate for:
Sirtuins (SIRT1–7):: A family of enzymes linked to longevity, metabolic regulation, DNA repair, and inflammation control. Sirtuins cannot function without NAD+.
PARP enzymes:: Primary mediators of DNA damage repair. PARP activity is NAD+-dependent.
CD38:: An enzyme that degrades NAD+; its activity increases with age and inflammation, accelerating NAD+ decline.
The Decline With Age
Landmark research from Harvard Medical School and the National Institute on Aging has documented that NAD+ levels in human tissue decline by approximately 50% between the ages of 40 and 60. This decline correlates with reduced mitochondrial function, increased DNA damage accumulation, and the metabolic and physical deterioration characteristic of aging.
Animal studies restoring NAD+ to young-adult levels have shown reversal of multiple age-related phenotypes — including muscle function, vascular health, and metabolic efficiency.
Why Injectable NAD+ Outperforms Oral Precursors
Oral NAD+ precursors — NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) — must be absorbed, transported into cells, and enzymatically converted to NAD+ through multiple steps. Injectable NAD+ delivers NAD+ directly to the bloodstream, achieving significantly higher and faster plasma concentration increases.
For patients seeking rapid restoration — particularly for energy, cognitive performance, or recovery support — injectable NAD+ provides the most direct and predictable response.
Clinical Applications
Enhanced mitochondrial energy production and reduction in fatigue
Cognitive clarity and working memory support
Accelerated recovery from exercise and physical stress
Systemic anti-aging support through sirtuin and PARP activation
Support for patients with chronic fatigue, post-viral syndromes, or alcohol recovery
Injectable NAD+ is a prescription-grade formulation. Eligibility and protocol are determined by a licensed provider based on clinical goals and health history.
